跳至主要内容
临床试验/CTRI/2015/04/005677
CTRI/2015/04/005677招募中4 期

A study of efficacy and safety profile of amitriptyline and agomelatine in Major Depressive Disorder.

MYSORE MEDICAL COLLEGE AND RESEARCH INSTITUTE0 个研究点目标入组 66 人开始时间: 待定最近更新:

试验速览

阶段
4 期
状态
招募中
发起方
入组人数
66

研究概览

简要总结

暂无简介。

研究设计

研究类型
Pms

入排标准

入选标准

  • Subjects diagnosed with major depressive disorder, single episode- according to Diagnostic and Statistical Manual of Mental disorders 5 (DSM 5) criteria.
  • Age between 18 - 60 years.
  • Subjects who give informed consent.

排除标准

  • Subjects with history of bipolar disorder, schizophrenia, schizoaffective disorder.
  • Subjects with suicidal tendencies.
  • Subjects with altered liver function.
  • Subjects with any serious concurrent illness.
  • Presence of organic brain syndrome (delirium, dementia).
  • Presence of alcohol and substance abuse/dependence, epilepsy, mental retardation, pregnancy and lactation.
  • Subjects who are on antidepressant medication.

研究者

发起方
MYSORE MEDICAL COLLEGE AND RESEARCH INSTITUTE

相似试验